Exploring genetic and immune underpinnings of the sexual dimorphism in tumor response to immune checkpoints inhibitors: A narrative review
Introduction: In spite of the undisputed relevance of sex as critical biologic variable of the immune landscape, still limited is our understanding of the basic mechanisms implicated in sex-biased immune response thereby conditioning the therapeutic outcome in cancer patients. This hindrance delays...
Main Authors: | Giulia Mazzaschi, Federico Quaini, Sebastiano Buti |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Current Research in Pharmacology and Drug Discovery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590257122000669 |
Similar Items
-
Role of Microbiota in Sexually Dimorphic Immunity
by: Marlies Elderman, et al.
Published: (2018-05-01) -
Sex — a potential factor affecting immune checkpoint inhibitor therapy for cancers
by: Wang Hu, et al.
Published: (2022-10-01) -
Editorial: Differential Efficacy of Immune Checkpoint Inhibitors due to Age and Sex Factors
by: Pei Pei Chong, et al.
Published: (2022-06-01) -
Sex Differences in the Efficacy of Immune Checkpoint Inhibitors in Neoadjuvant Therapy of Non-Small Cell Lung Cancer: A Meta-Analysis
by: Guillermo Suay, et al.
Published: (2023-09-01) -
Microglial and peripheral immune priming is partially sexually dimorphic in adolescent mouse offspring exposed to maternal high-fat diet
by: Maude Bordeleau, et al.
Published: (2020-09-01)